This can explain why we observe the significantly increased risk of cancer in LS patients compared to LS cancer-free patients and makes SNP rs2075786 a plausible modifier for disease risk in MSH2 pathogenic variant carriers. Here, MSH2 is linked to Leigh syndrome.